ACURX PHARMACEUTICALS INC (ACXP)

US00510M1045 - Common Stock

0.7974  +0.05 (+6.18%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
16.44M14.58M12.09M12.82M4.60M
Research and Development
6.52M6.04M4.75M2.03M2.20M
Selling, General, and Administrative Expenses
9.91M8.53M7.34M10.78M2.40M
Operating Income
-16.44M-14.58M-12.09M-12.82M-4.60M
Non Recurring Items
N/AN/A0.0070.00KN/A
Income Before Taxes
-16.44M-14.58M-12.09M-12.75M-4.60M
Net Income
-16.44M-14.58M-12.09M-12.75M-4.60M
 
Per Share Data
EPS Diluted Total Ops
-1.09-1.15-1.12-1.49-0.48
Non GAAP EPS
-1.08-1.14N/AN/AN/A
 
Statistics

All data in USD

Charts